Lexington Biosciences Receives HeartSentry USPTO Patent Approval
25. Juli 2018 09:00 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, July 25, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Lexington Releases Audited Consolidated Financial Statements
30. April 2018 20:18 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, April 30, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, has...
Lexington Delivers 1st Generation HeartSentry for Clinical Trials
13. Februar 2018 09:00 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...